A. Kassa

发表

Track A Basic Science

S. Sugden, D. Hazuda, F. Pereyra, 2012, Journal of the International AIDS Society.

Stabilizing Exposure of Conserved Epitopes by Structure Guided Insertion of Disulfide Bond in HIV-1 Envelope Glycoprotein

E. Go, H. Desaire, D. Montefiori, 2013, PloS one.

Identification of a Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Variant Resistant to Cold Inactivation

J. Sodroski, M. Pancera, Amos B. Smith, 2009, Journal of Virology.

Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.

T. Ross, D. Swayne, T. Mebatsion, 2021, Vaccine.

Synthesis of a trimeric gp120 epitope mimic conjugated to a T-helper peptide to improve antigenicity.

Joan G. Schellinger, I. Srivastava, A. Kassa, 2011, Journal of the American Chemical Society.

Designing Immunogens for Vaccine Development in Reference to HIV

I. Srivastava, A. Kassa, P. Sarkar, 2011 .

Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State

J. Sodroski, Liping Wang, Amy M. Princiotto, 2009, PLoS pathogens.

Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits.

J. Sodroski, Xinzhen Yang, A. Kassa, 2003, Virology.

Contribution of Intrinsic Reactivity of the HIV-1 Envelope Glycoproteins to CD4-Independent Infection and Global Inhibitor Sensitivity

J. Sodroski, Liping Wang, M. Seaman, 2011, PLoS pathogens.

Transitions to and from the CD4-Bound Conformation Are Modulated by a Single-Residue Change in the Human Immunodeficiency Virus Type 1 gp120 Inner Domain

J. Sodroski, E. Freire, P. Kwong, 2009, Journal of Virology.

Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.

J. Sodroski, P. Kwong, S. Xiang, 2010, Molecular cell.

Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses.

T. Ross, D. Swayne, T. Mebatsion, 2023, Vaccine.